Insider buying · SEC Form 4

Insider Buying — Jul 23, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

8insider buys
$9.69Mbought in total
4companies
4by CEOs, CFOs and other chiefs
PBLSlargest: $6.92M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
PBLSParabilis Medicines, Inc.RA Capital Management, L.P. (Peter Kolchinsky / Rajeev M. Shah)10% Owner / Director$6.92M244,593$28.28AddedJul 22, 2026
Form 4 ↗
6 open-market transactions Jul 20–22 at weighted avg prices $27.13–$30.00/share. RA Capital Healthcare Fund LP and RA Capital Nexus Fund III LP purchased jointly; total beneficial ownership ~29.2M shares. Stock now $30.81 (+8.9% vs $28.29 blended avg buy price). No specific earnings catalyst identified; aggressive accumulation at rising prices.
CLBKColumbia Financial, Inc.Thomas J. KemlyPresident & CEO$531K53,057$10.00AddedJul 22, 2026
Form 4 ↗
Second-step mutual-to-stock conversion subscription at $10.00/share (Jul 20, 2026). 40,000 shares direct + 13,057 via 401(k). Stock now $10.94 (+9.4%). Part of 16-insider cluster filing on the same day; CLBK began Nasdaq trading Jul 21, 2026 after $1.7B capital raise and Northfield Bancorp acquisition close.
CLBKColumbia Financial, Inc.Allyson Katz SchlesingerSEVP & Head of Consumer Banking$500K50,000$10.00AddedJul 22, 2026
Form 4 ↗
Second-step conversion subscription at $10.00/share (Jul 20, 2026). 44,400 direct + 5,600 shares in second tranche. Stock now $10.94 (+9.4%).
CLBKColumbia Financial, Inc.Steven M KleinSr. EVP & COO$500K50,000$10.00AddedJul 22, 2026
Form 4 ↗
Second-step conversion subscription at $10.00/share (Jul 20, 2026). Stock now $10.94 (+9.4%). Post-transaction holdings: 711,570 direct shares.
HDSNHudson Technologies, Inc.Hartree Partners, LP10% Owner$393K65,550$5.99AddedJul 22, 2026
Form 4 ↗
2 open-market purchases: 17,842 shares at $5.9892 (Jul 20) + 47,708 shares at $5.9894 (Jul 21). Post-transaction: 5,042,086 shares. No 10b5-1 plan indicated. Stock now $6.19 (+3.4% vs $5.989 blended avg buy). Refrigerant reclamation sector; 10% owner adding at multi-year lows.
CLBKColumbia Financial, Inc.John KlimowichSEVP & Chief Risk Officer$350K35,000$10.00AddedJul 22, 2026
Form 4 ↗
Second-step conversion subscription at $10.00/share (Jul 20, 2026). 5,000 direct + 30,000 via 401(k). Stock now $10.94 (+9.4%).
NMMNavios Maritime Partners L.P.Angeliki FrangouCEO & Chairwoman of the Board$253K3,437$73.68AddedJul 22, 2026
Form 4 ↗
3 open-market purchases Jul 20–22 via Rule 10b5-1 plan (Raymar Investments S.A. / UBS Financial Services, plan adopted Dec 9, 2025): 1,167 shares @$72.95, 1,149 @$74.03, 1,121 @$74.07. Also a director/10% owner. Stock now $73.66 (-0.0% vs $73.68 avg). Automated plan reduces discretionary signal.
CLBKColumbia Financial, Inc.Robert Van DykDirector$250K25,000$10.00AddedJul 22, 2026
Form 4 ↗
Second-step conversion subscription at $10.00/share (Jul 20, 2026). Post-transaction: 322,013 direct shares. Stock now $10.94 (+9.4%).

AIThe day in insider buying

SEC Form 4 Insider Scan — July 23, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 8 qualifying buys (≥ $250K, transaction type P) totalling $9.7M.

Headline Filings

  • PBLS — RA Capital Management, L.P. (10% Owner / Director) bought 244,593 shares ≈ $6.9M across 6 transactions (Jul 20–22) at $28.29 weighted avg; now $30.81 (+8.9% since buy). (filing)
  • CLBK — Thomas J. Kemly (President & CEO) bought 53,057 shares ≈ $530.6K at $10.00; now $10.94 (+9.4% since buy). (filing)
  • CLBK — Allyson Katz Schlesinger (SEVP & Head of Consumer Banking) bought 50,000 shares ≈ $500K at $10.00; now $10.94 (+9.4%). (filing)
  • CLBK — Steven M Klein (Sr. EVP, COO) bought 50,000 shares ≈ $500K at $10.00; now $10.94 (+9.4%). (filing)
  • HDSN — Hartree Partners, LP (10% Owner) bought 65,550 shares ≈ $393K at $5.99 avg (Jul 20–21); now $6.19 (+3.4% since buy). (filing)
  • CLBK — John Klimowich (SEVP & Chief Risk Officer) bought 35,000 shares ≈ $350K at $10.00; now $10.94 (+9.4%). (filing)
  • NMM — Angeliki Frangou (CEO & Chairwoman) bought 3,437 shares ≈ $253K at $73.68 avg (Jul 20–22) via 10b5-1 plan; now $73.66 (-0.0%). (filing)
  • CLBK — Robert Van Dyk (Director) bought 25,000 shares ≈ $250K at $10.00; now $10.94 (+9.4%). (filing)

Notes

Dominant theme — CLBK second-step conversion cluster. Columbia Financial (CLBK) completed its mutual-to-stock second-step conversion on July 20–21, 2026, raising $1.7B at $10/share and simultaneously closing a $580M acquisition of Northfield Bancorp. Five qualifying insiders — CEO, COO, and three senior EVPs — subscribed a combined $2.13M to conversion shares. These are subscription purchases (not open-market), but all are coded "P" in Form 4 and represent real cash commitments. CLBK is already trading at a ~9.4% premium to the $10.00 offering price just two trading sessions in.

PBLS — aggressive institutional accumulation in biotech. RA Capital Management (a specialist healthcare fund) accumulated 244,593 additional PBLS shares across six sessions at rising prices ($27.13 → $30.00), for nearly $6.9M. With ~29.2M shares post-buy, RA Capital holds a dominant stake in this recently-public biotech. The willingness to buy at the top of the range is a strong vote of confidence.

HDSN — 10% owner quietly adding. Hartree Partners bought 65,550 shares of Hudson Technologies at ~$5.99 on Jul 20–21. Hudson is a refrigerant reclamation company under pressure from pricing normalization; a large 10% holder continuing to build at current levels signals conviction in a near-term recovery.

NMM — 10b5-1 context. Frangou's NMM purchase was executed under a pre-scheduled Rule 10b5-1 plan adopted December 9, 2025. Carries less discretionary signal than the other filings — plan was set up months ago.

Most-bought stocks, last 30 days

  • AVO $65.6M · 11 buys, 3 insidersMission Produce, Inc.
  • PBLS $16.9M · 2 buys, 2 insidersParabilis Medicines, Inc.
  • COE $12.1M · 3 buysChina Online Education Group
  • PSEC $9.35M · 3 buys, 2 insidersProspect Capital Corp
  • NTSK $7.53M · 2 buys, 2 insidersNetskope Inc.
  • HDSN $6.49M · 3 buys, 2 insidersHudson Technologies, Inc.
  • NVCT $4.66M · 8 buys, 2 insidersNuvectis Pharma, Inc.
  • ENR $3.71M · 3 buys, 2 insidersEnergizer Holdings, Inc.
  • GLOO $3.50M · 1 buyGloo Holdings, Inc.
  • WBX $2.25M · 2 buys, 2 insidersWallbox N.V.
  • CLBK $2.13M · 5 buys, 5 insidersColumbia Financial, Inc.
  • GGAL $2.09M · 1 buyGrupo Financiero Galicia S.A.
  • NXST $1.99M · 1 buyNexstar Media Group, Inc.
  • ADBE $1.95M · 1 buyAdobe Inc
  • RH $1.83M · 1 buyRH
  • JCTC $1.61M · 2 buys, 2 insidersJewett-Cameron Trading Co. Ltd.
  • FULC $1.48M · 2 buys, 2 insidersFulcrum Therapeutics, Inc.
  • AMS $1.34M · 1 buyAmerican Shared Hospital Services
  • BOLD $1.25M · 3 buys, 2 insidersBoundless Bio, Inc.
  • LILA $1.00M · 1 buyLiberty Latin America Ltd.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.